Zoetis PFL.5196 Bovi-Shield Gold® 5 Vaccine, 10 Dose, For Cattle
Product Code: PFL.5196
Bovi-Shield Gold® 5 Vaccine, 10 Dose, Vial Container, Solid, Liquid Form, 6 - 8 pH, >212 Deg F Boiling Point, 2 - 7 Deg C Storage Temperature, <0.1% Gentamicin, Bovine Parainfluenza 3, Bovine Respiratory Syncytial Virus, Bovine Rhinotracheitis, Bovine Virus Diarrhea, Sterile Diluent, Cattle Species
- Container Type : Vial
- Dosage : 10 Dose
- Ingredients : <0.1% Gentamicin, Bovine Parainfluenza 3, Bovine Respiratory Syncytial Virus, Bovine Rhinotracheitis, Bovine Virus Diarrhea, Sterile Diluent
- Boiling Point : >212 Deg F
- Form : Solid, Liquid
- pH Value : 6 - 8 pH
- Species : Cattle
- Storage Temperature : 2 - 7 Deg C
Bovi-Shield Gold 5 is for the vaccination of healthy cattle as an aid in preventing infectious bovine rhinotracheitis caused by infectious bovine rhinotracheitis (IBR) virus, bovine viral diarrhea caused by bovine virus diarrhea (BVD) virus Types 1 and 2 and disease caused by parainfluenza3 (PI3) virus and bovine respiratory syncytial virus (BRSV). Bovi-Shield GOLD 5 may be administered to pregnant cattle provided they were vaccinated, according to label directions, with any Bovi-Shield GOLD FP® or PregGuard® GOLD FP vaccine within the past 12 months. Bovi-Shield GOLD 5 may also be administered to calves nursing pregnant cows provided their dams were vaccinated within the past 12 months as described above. Bovi-Shield GOLD 5 is a freeze-dried preparation of modified live virus (MLV) strains of IBR, BVD (Types 1 and 2), PI3 and BRSV viruses, plus a sterile diluent used to rehydrate the freeze-dried vaccine. Viral antigens are propagated on established cell lines. Precautions: Do not use in pregnant cows (abortions can result) unless they were vaccinated, according to label directions, with any Bovi-Shield GOLD FP PregGuard GOLD FP vaccine within the past 12 months. Do not use in calves nursing pregnant cows unless their dams were vaccinated within the past 12 months as described above. •Consistent with good vaccination practices, it is recommended that heifers receive at least 2 doses with the second dose administered approximately 30 days prebreeding. •Store at 2°–7°C Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency. Do not freeze. •Use entire contents when first opened. •Sterilized syringes and needles should be used to administer this vaccine. •Do not sterilize with chemicals because traces of disinfectant may inactivate the vaccine. Burn containers and all unused contents. •Do not vaccinate within 21 days before slaughter. •Contains gentamicin as preservative. •As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy. •This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised or the vaccine is not administered in accordance with label directions.
General Directions: Vaccination of healthy cattle is recommended. Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided, shake well, and administer 2 mL subcutaneously or intramuscularly. In accordance with Beef Quality Assurance guidelines, this product should be administered SC or IM in the neck region. Primary Vaccination: Administer a single 2-mL dose to healthy cattle. Revaccination: Annual revaccination with a single dose is recommended. Good animal husbandry and herd health management practices should be employed.